Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.740
+0.040 (2.35%)
At close: Sep 26, 2025, 4:00 PM EDT
1.770
+0.030 (1.72%)
After-hours: Sep 26, 2025, 7:44 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $281.79 million as of September 26, 2025. Its market cap has decreased by -84.55% in one year.
Market Cap
281.79M
Enterprise Value
84.16M
1-Year Change
-84.55%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $281.79M, a decrease of -89.09%. That is a compound annual growth rate of -66.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 281.79M | -83.55% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |